CAS 86-22-6|brompheniramine

Introduction:Basic information about CAS 86-22-6|brompheniramine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common Namebrompheniramine
CAS Number86-22-6Molecular Weight319.23900
Density1.265 g/cm3Boiling Point403ºC at 760 mmHg
Molecular FormulaC16H19BrN2Melting Point/
MSDS/Flash Point197.5ºC

Names

Namebrompheniramine
SynonymMore Synonyms

brompheniramine BiologicalActivity

DescriptionBrompheniramine ((±)-Brompheniramine) is a potent and orally active antihistamine of the alkylamine class. Brompheniramine is a selective histamine H1 receptor antagonist with a Kd of 6.06 nM. Brompheniramine can block the hERG channels, calcium channels, and sodium channels with IC50s of 0.90 μM, 16.12 μM and 21.26 μM, respectively. Brompheniramine has anticholinergic, antidepressant and anesthetic properties and can be used for allergic rhinitis research[1][2][3][4].
Related CatalogSignaling Pathways >>Membrane Transporter/Ion Channel >>Sodium ChannelSignaling Pathways >>Membrane Transporter/Ion Channel >>Calcium ChannelSignaling Pathways >>Neuronal Signaling >>mAChRSignaling Pathways >>Immunology/Inflammation >>Histamine ReceptorResearch Areas >>EndocrinologySignaling Pathways >>GPCR/G Protein >>mAChRResearch Areas >>Inflammation/ImmunologyResearch Areas >>Neurological DiseaseSignaling Pathways >>Membrane Transporter/Ion Channel >>Potassium ChannelSignaling Pathways >>GPCR/G Protein >>Histamine Receptor
In VitroBrompheniramine (0.1-100 μM) blocks hERG K+ channels expressed in CHO cells in a concentration-dependent manner with an IC50 of 0.90±0.14 μM, and reduced peak tail current amplitude measured at -60 mV (cells are depolarized for 2 s to +20 mV from a holding potential of -80 mV followed by a 3s repolarization back to -60 mV)[3]. Brompheniramine (1, 10 and 100 μM) significantly shortens the APD50 and depresses the plateau phase on the action potential in guinea pig papillary muscle, as well as slightly prolongs the APD90 in guinea pig papillary muscle at 10 and 100 μM[3]. Brompheniramine (0.1-100 μM) inhibit the amplitude of the Ca2+ channel currents in rat ventricular myocytes by 14.1±1.1, 31.1±5.8, 38.0±3.8 and 90.2±3.7% at 0.1, 1, 10 and 100 μM, respectively[3]. Brompheniramine blocks muscarinic cholinergic receptors in human chinese hamster ovary (CHO) cells[4].
In VivoBrompheniramine (0.3-3 μM; SC, single dosage) induces cutaneous analgesia in rats[1]. Animal Model: Male Sprague-Dawley rats[1] Dosage: 0.3, 0.6, 1.1, 1.5 and 3.0  μM Administration: SC, single dosage Result: Provoked cutaneous analgesia in a dose-dependent manner, with an EC50 value of 0.66 μM, and induced prolonged analgesic duration.
References

[1]. Chong-Chi Chiu, et al. Subcutaneous brompheniramine for cutaneous analgesia in rats. Eur J Pharmacol. 2019 Oct 5;860:172544.

[2]. B Cusack, et al. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65.

[3]. Shin WH, Kim KS, Kim EJ. Electrophysiological effects of brompheniramine on cardiac ion channels and action potential. Pharmacol Res. 2006 Dec;54(6):414-20.

[4]. Yasuda SU, Yasuda RP. Affinities of brompheniramine, chlorpheniramine, and terfenadine at the five human muscarinic cholinergic receptor subtypes. Pharmacotherapy. 1999 Apr;19(4):447-51.

Chemical & Physical Properties

Density1.265 g/cm3
Boiling Point403ºC at 760 mmHg
Molecular FormulaC16H19BrN2
Molecular Weight319.23900
Flash Point197.5ºC
Exact Mass318.07300
PSA16.13000
LogP3.92770
Index of Refraction1.577
InChIKeyZDIGNSYAACHWNL-UHFFFAOYSA-N
SMILESCN(C)CCC(c1ccc(Br)cc1)c1ccccn1
Storage condition2-8°C

Synonyms

Brompheniramine
MFCD00865691
EINECS 201-657-8
(+/-)-1-(4-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane
(±)-brompheniramine
CAS 86194-41-4|α-HCH D6
CAS 862372-86-9|(R)-3,3-DIMETHYL-1,1-BINAPHTHALENE-2,2-DIOL
Recommended......
TOP